Intellectual Property India Publishes Patent Application for 'Aminothiols For The Treatment Of Conditions Characterized By Protein Misfolding Or Aggregation, Mitochondrial Dysfunction, Or Chronic Inflammation' Filed by Obvia Pharmaceuticals, Ltd.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202547085481 A) filed by Obvia Pharmaceuticals, Ltd., Madison, U.S.A., on Sept. 9, for 'aminothiols for the treatment of conditions characterized by protein misfolding or aggregation, mitochondrial dysfunction, or chronic inflammation.'

Inventor(s) include Fahl, William; Goesch, Torsten; Goesch, Hannah, Rebecca; and Goesch, Sarah, Ricarda.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The invention features aminothiols for treating (1 ) diseases and conditions characterized by misfolding and/or aggregation of endogenous proteins, (2) diseases ...